🇺🇸 somatropin - GH naïve pediatric cohort in United States

somatropin - GH naïve pediatric cohort (somatropin-gh-na-ve-pediatric-cohort) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

somatropin - GH naïve pediatric cohort in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is somatropin - GH naïve pediatric cohort approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for somatropin - GH naïve pediatric cohort in United States?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.